NCT00731562View on ClinicalTrials.gov

An Investigation Of The Effects Of Food On The Absorption Of A Varenicline Controlled Release Formulation

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
PharmacokineticsBioavailabilitySmoking Cessation
Interventions
DRUG

Varenicline Tartrate Controlled Release

A single, 2.4 mg dose of a varenicline controlled release tablet administered orally under fasted conditions

DRUG

Varenicline Tartrate Controlled Release

A single, 2.4 mg dose of a varenicline controlled release tablet administered orally under fed conditions

Trial Locations (2)

56721

Pfizer Investigational Site, East Grand Forks

58104

Pfizer Investigational Site, Fargo

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY